Alfresa Holdings Corporation (TYO:2784)

Market Cap	358.40B
Revenue (ttm)	2.96T
Net Income (ttm)	27.39B
Shares Out	181.79M
EPS (ttm)	147.54
PE Ratio	13.36
Forward PE	11.96
Dividend	68.00 (3.45%)
Ex-Dividend Date	Mar 28, 2025

Volume	531,300
Average Volume	408,705
Open	1,960.50
Previous Close	1,971.50
Day's Range	1,958.50 - 1,984.50
52-Week Range	1,897.00 - 2,473.50
Beta	-0.12
RSI	50.96
Earnings Date	Aug 6, 2025

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements,...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,452
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2784

Financial Performance

In 2024, Alfresa Holdings's revenue was 2.96 trillion, an increase of 3.59% compared to the previous year's 2.86 trillion. Earnings were 27.39 billion, a decrease of -7.34%.